Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Equity (2016 - 2025)

Historic Return on Equity for Iradimed (IRMD) over the last 12 years, with Q3 2025 value amounting to 0.21%.

  • Iradimed's Return on Equity changed 0.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.23% for FY2024, which is 200.0% up from last year.
  • Per Iradimed's latest filing, its Return on Equity stood at 0.21% for Q3 2025, which was down 0.0% from 0.22% recorded in Q2 2025.
  • Over the past 5 years, Iradimed's Return on Equity peaked at 0.23% during Q3 2023, and registered a low of 0.02% during Q1 2021.
  • For the 5-year period, Iradimed's Return on Equity averaged around 0.18%, with its median value being 0.21% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -1500bps in 2021, then skyrocketed by 1300bps in 2022.
  • Quarter analysis of 5 years shows Iradimed's Return on Equity stood at 0.13% in 2021, then surged by 34bps to 0.18% in 2022, then rose by 21bps to 0.22% in 2023, then rose by 1bps to 0.22% in 2024, then fell by -2bps to 0.21% in 2025.
  • Its Return on Equity stands at 0.21% for Q3 2025, versus 0.22% for Q2 2025 and 0.22% for Q1 2025.